Cancer immunotherapy: In vivo imaging of adoptively transferred T cells in an immunocompetent host

per Sharma, Padmanee
Publicat 2010

Immune Checkpoint Therapy as a Weapon against Cancer

per Sharma, Padmanee
Publicat a Cancer J (2016)

Immune Checkpoint Therapy and the Search for Predictive Biomarkers

per Sharma, Padmanee
Publicat a Cancer J (2016)

Targeting the tumor niche to treat cancer

per Neelapu, Sattva S., Sharma, Padmanee
Publicat a Proc Natl Acad Sci U S A (2015)

Current and Emerging Treatment Options for Castration-Resistant Prostate Cancer: A Focus on Immunotherapy

per Gerritsen, Winald R., Sharma, Padmanee
Publicat 2011

Immune Checkpoint Targeting in Cancer Therapy: Towards Combination Strategies with Curative Potential

per Sharma, Padmanee, Allison, James P.
Publicat a Cell (2015)

Immunotherapeutic Strategies for High-Risk Bladder Cancer

per Sharma, Padmanee, Old, Lloyd J., Allison, James P.
Publicat a Semin Oncol (2007)

Novel cancer immunotherapy agents with survival benefit: recent successes and next steps

per Sharma, Padmanee, Wagner, Klaus, Wolchok, Jedd D., Allison, James P.
Publicat 2011

Monitoring immune responses in the tumor microenvironment

per Wargo, Jennifer A., Reddy, Sangeetha M., Reuben, Alexandre, Sharma, Padmanee
Publicat a Curr Opin Immunol (2016)

Primary, Adaptive and Acquired Resistance to Cancer Immunotherapy

per Sharma, Padmanee, Hu-Lieskovan, Siwen, Wargo, Jennifer A., Ribas, Antoni
Publicat a Cell (2017)

Advances in the Development of Cancer Immunotherapies

per Gao, Jianjun, Bernatchez, Chantale, Sharma, Padmanee, Radvanyi, Laszlo G., Hwu, Patrick
Publicat 2012

Cancer Immunotherapy: Sipuleucel-T and Beyond

per Hammerstrom, Aimee E., Cauley, Diana H., Atkinson, Bradley J., Sharma, Padmanee
Publicat 2011

Concurrent decrease in IL-10 with development of immune-related adverse events in a patient treated with anti-CTLA-4 therapy

per Sun, Jingjing, Schiffman, Jade, Raghunath, Anitha, Ng Tang, Derek, Chen, Hong, Sharma, Padmanee
Publicat 2008

Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer

per Liakou, Chrysoula I., Narayanan, Sowmita, Ng Tang, Derek, Logothetis, Christopher J., Sharma, Padmanee
Publicat 2007

Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy

per Fan, Xiaozhou, Quezada, Sergio A., Sepulveda, Manuel A., Sharma, Padmanee, Allison, James P.
Publicat 2014

Reversing gp100/IFA-induced impairment of anti-CTLA-4 checkpoint blockade therapy

per Hailemichael, Yared, Fu, Tihui, Khong, Hiep, Dai, Zhimin, Sharma, Padmanee, Overwijk, Willem W
Publicat a J Immunother Cancer (2014)

The emerging role of immune checkpoint based approaches in AML and MDS

per Boddu, Prajwal, Kantarjian, Hagop, Garcia-Manero, Guillermo, Allison, James, Sharma, Padmanee, Daver, Naval
Publicat a Leuk Lymphoma (2017)

Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer

per Raval, Raju R, Sharabi, Andrew B, Walker, Amanda J, Drake, Charles G, Sharma, Padmanee
Publicat 2014

Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibody

per Bilen, Mehmet Asim, Subudhi, Sumit K., Gao, Jianjun, Tannir, Nizar M., Tu, Shi-Ming, Sharma, Padmanee
Publicat a J Immunother Cancer (2016)

Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes

per Daver, Naval, Boddu, Prajwal, Garcia-Manero, Guillermo, Yadav, Shalini Singh, Sharma, Padmanee, Allison, James, Kantarjian, Hagop
Publicat a Leukemia (2018)